SCOPUS 정보 검색 플랫폼

Cancer Practice

Volumn 6, Issue 4, 1998, Pages 251-253

Liposomes as drug delivery systems

(1) Clark, Ann P a

a UNIVERSITY OF THE SCIENCES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTHRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DAUNORUBICIN; DOXORUBICIN; FLUOROURIDINE; IMMUNOLIPOSOME; LIPOSOME; NYSTATIN; PRODRUG; RETINOIC ACID; TOPOTECAN;

ALOPECIA; BONE MARROW SUPPRESSION; CHILL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; ENCAPSULATION; FEVER; GASTROINTESTINAL TOXICITY; HEART MUSCLE INJURY; HUMAN; MUCOSA INFLAMMATION; NEPHROTOXICITY; RETICULOENDOTHELIAL SYSTEM; REVIEW;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; HUMANS; LIPOSOMES; TREATMENT OUTCOME;

EID: 0031818232 PISSN: 10654704 EISSN: None Source Type: Journal
DOI: 10.1046/j.1523-5394.1998.006004251.x Document Type: Review

Times cited : (4)

References (10)

1
- 0030681273
- Liposomes: Opportunities in drug delivery
- Allen TM, Liposomes: opportunities in drug delivery. Drugs. 1997;54(suppl 4):8-14.
- (1997) Drugs , vol.54 , Issue.4 SUPPL. , pp. 8-14
- Allen, T.M.¹

2
- 0030900491
- Liposomes as carriers of antimicrobial drugs
- Siler-Marinkovic S, Mojovic L, Davinic V, Bugarski B. Liposomes as carriers of antimicrobial drugs. Drug Dev Ind Pharm. 1997;23(5):483-488.
- (1997) Drug Dev Ind Pharm , vol.23 , Issue.5 , pp. 483-488
- Siler-Marinkovic, S.¹ Mojovic, L.² Davinic, V.³ Bugarski, B.⁴

3
- 0030964439
- Colloidal systems for tumor targeting
- Storm G, Crommelin DJA. Colloidal systems for tumor targeting. Hybridoma. 1997;16(1):119-125.
- (1997) Hybridoma , vol.16 , Issue.1 , pp. 119-125
- Storm, G.¹ Crommelin, D.J.A.²

4
- 0030430048
- Liposomal drug delivery
- Ranson M, Howell A, Cheeseman S, Margison J. Liposomal drug delivery. Cancer Treat Rev. 1996;22:365-379.
- (1996) Cancer Treat Rev , vol.22 , pp. 365-379
- Ranson, M.¹ Howell, A.² Cheeseman, S.³ Margison, J.⁴

5
- 0030013420
- Fat pharms
- May M. Fat pharms. Environ Health Perspect. 1996; 104(4):390-392.
- (1996) Environ Health Perspect , vol.104 , Issue.4 , pp. 390-392
- May, M.¹

6
- 26844541464
- UHC Drug Monographs. Nov
- Gubbins PO. Liposomal Amphotericin B. UHC Drug Monographs. Nov 1997:1-29.
- (1997) Liposomal Amphotericin B , pp. 1-29
- Gubbins, P.O.¹

7
- 0029845811
- New treatments for breast cancer
- Smith G, Henderson IC. New treatments for breast cancer. Semin Oncol. 1996;23(4):506-528.
- (1996) Semin Oncol , vol.23 , Issue.4 , pp. 506-528
- Smith, G.¹ Henderson, I.C.²

8
- 0030990935
- Polyethylene glycol-liposomal doxorubicin
- Coukell AJ, Spencer CM. Polyethylene glycol-liposomal doxorubicin. Drugs. 1997;53(3):520-538.
- (1997) Drugs , vol.53 , Issue.3 , pp. 520-538
- Coukell, A.J.¹ Spencer, C.M.²

9
- 0030840832
- Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs
- Crosasso P, Brusa P, Dosio F, et al. Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs. J Pharm Sci. 1997;86(7):832-839.
- (1997) J Pharm Sci , vol.86 , Issue.7 , pp. 832-839
- Crosasso, P.¹ Brusa, P.² Dosio, F.³

10
- 0029593371
- Liposomal encapsulation creases the activity of the topoisomerase I inhibitor topetecan
- Subramanian D, Muller MT. Liposomal encapsulation creases the activity of the topoisomerase I inhibitor topetecan. Oncol Res. 1995;7(9):461-469.
- (1995) Oncol Res , vol.7 , Issue.9 , pp. 461-469
- Subramanian, D.¹ Muller, M.T.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.